Novozymes A/S – (NVZMY) Receives New Coverage from Analysts at Deutsche Bank AG

Deutsche Bank AG initiated coverage on shares of Novozymes A/S – (NASDAQ:NVZMY) in a research report released on Friday, The Fly reports. The brokerage issued a hold rating on the stock.

A number of other analysts also recently commented on the stock. Zacks Investment Research downgraded shares of Novozymes A/S – from a hold rating to a sell rating in a report on Thursday, August 25th. Berenberg Bank started coverage on shares of Novozymes A/S – in a report on Tuesday, September 27th. They set a sell rating for the company.

Novozymes A/S – (NASDAQ:NVZMY) opened at 42.579 on Friday. The company has a market cap of $12.79 billion and a P/E ratio of 29.776. Novozymes A/S – has a 52 week low of $37.98 and a 52 week high of $49.55. The company has a 50-day moving average of $43.64 and a 200-day moving average of $46.06.

About Novozymes A/S –

Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. In June 2013, the Company restructured its sales areas within those segments. The Household Care (old Household Care Enzymes) area comprises cleaning solutions, laundry, dishwashing and microorganism sales for cleaning solutions.

5 Day Chart for NASDAQ:NVZMY

The Fly

Receive News & Ratings for Novozymes A/S - Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S - and related companies with's FREE daily email newsletter.

Leave a Reply

© 2006-2016 Mideast Time.